Anaphylaxis to dyes during the perioperative period: Reports of 14 clinical cases

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 2, 2008, Pages 348-352

  Mertes, Paul Michel ^a   Malinovsky, Jean Marc ^b   Mouton Faivre, Claudie ^a   Bonnet Boyer, Marie Caroline ^d   Benhaijoub, Abdelhaouad ^a   Lavaud, François ^c   Valfrey, Jocelyne ^e   O'Brien, James ^a   Pirat, Philippe ^f   Lalourcey, Laurent ^g   Demoly, Pascal ^h  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Service d'Anesthésie Réanimation   (France)

^c HÔPITAL MAISON BLANCHE   (France)

^d LAPEYRONIE HOSPITAL   (France)

^e HÔPITAL CIVIL   (France)

^f GUI DE CHAULIAC HOSPITAL   (France)

^g CENTRE VAL D AURELLE   (France)

^h HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

allergy; anaphylaxis; dye; intradermal test; Patent Blue; prick test; sentinel lymph node

Indexed keywords

ADRENALIN; DYE;

ADULT; AGED; ANAPHYLAXIS; ANESTHESIA; ARTICLE; CLINICAL ARTICLE; HUMAN; HYPERSENSITIVITY REACTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PATIENT CARE; PERIOPERATIVE PERIOD; PRICK TEST; PRIORITY JOURNAL;

EID: 48449091477     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.04.040     Document Type: Article

References (46)

1. Al-Fadly W., Davis H.A., Gibson L.H., Hinshaw D.B., and Ratzlaff K.O. New method for determination of the cardiac output by means of the dye, patent blue A; preliminary observations. Med Arts Sci 10 (1956) 43-46
2. Van Vaerenbergh P.M. Immediate hypersensitivity after injection of patent blue violet. J Belge Radiol 50 (1967) 411-412
3. Lingam M.K., Mackie R.M., and McKay A.J. Intraoperative identification of sentinel lymph node in patients with malignant melanoma. Br J Cancer 75 (1997) 1505-1508
4. Cimmino V.M., Brown A.C., Szocik J.F., Pass H.A., Moline S., De S.K., et al. Allergic reactions to isosulfan blue during sentinel node biopsy-a common event. Surgery 130 (2001) 439-442
5. Pevny I., and Bohndorf W. Group allergy due to patent blue sensitization. Med Klin 67 (1972) 698-702
6. van Zuuren E., Polderman M.C., and Kuijken I. Anaphylaxis to patent blue during sentinel lymph node identification. Contact Dermatitis 53 (2005) 171
7. Wohrl S., Focke M., Hinterhuber G., Stingl G., and Binder M. Near-fatal anaphylaxis to patent blue V. Br J Dermatol 150 (2004) 1037-1038
8. Woltsche-Kahr I., Komericki P., Kranke B., Brabek E., Horn M., Schuller-Petrovic S., et al. Anaphylactic shock following peritumoral injection of patent blue in sentinel lymph node biopsy procedure. Eur J Surg Oncol 26 (2000) 313-314
9. Mertes P.M., Laxenaire M.C., Lienhart A., Aberer W., Ring J., Pichler W.J., et al. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol 15 (2005) 91-101
10. Keller B., Yawalkar N., Pichler C., Braathen L.R., and Hunger R.E. Hypersensitivity reaction against patent blue during sentinel lymph node removal in three melanoma patients. Am J Surg 193 (2007) 122-124
11. Thevarajah S., Huston T.L., and Simmons R.M. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 189 (2005) 236-239
12. Laurie S.A., Khan D.A., Gruchalla R.S., and Peters G. Anaphylaxis to isosulfan blue. Ann Allergy Asthma Immunol 88 (2002) 64-66
13. Hadar T., Gimmon Z., and Shalit M. Giant blue urticaria following injection of patent blue dye for sentinel lymph node biopsy. Plast Reconstr Surg 117 (2006) 1657-1659
14. Scherer K., Studer W., Figueiredo V., and Bircher A.J. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol 96 (2006) 497-500
15. Scherer K., Bircher A.J., and Figueiredo V. Blue dyes in medicine-a confusing terminology. Contact Dermatitis 54 (2006) 231-232
16. Mertes P.M., and Laxenaire M.C. Adverse reactions to neuromuscular blocking agents. Curr Allergy Asthma Rep 4 (2004) 7-16
17. Mertes P.M., and Laxenaire M.C. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 19 (2002) 240-262
18. Mertes P.M., Alla F., and Laxenaire M.C. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 99 (2003) 536-545
19. Biran S., and Hochman A. Allergic reaction to patent blue during lymphangiography. Radiol Clin Biol 42 (1973) 166-168
20. Bilchik A.J., Giuliano A., Essner R., Bostick P., Kelemen P., Foshaq L.J., et al. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am 4 (1998) 351-358
21. Kalimo K., Jansen C.T., and Kormano M. Sensitivity to Patent Blue dye during skin-prick testing and lymphography. A retrospective and prospective study. Radiology 141 (1981) 365-367
22. Cox C.E., Salud C.J., and Harrinton M.A. The role of selective sentinel lymph node dissection in breast cancer. Surg Clin North Am 80 (2000) 1759-1777
23. Montgomery L.L., Thorne A.C., Van Zee K.J., Fey J., Heerdt A.S., Gemignani M., et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 95 (2002) 385-388
24. King T.A., Fey J.V., Van Zee K.J., Heerdt A.S., Gemignani M.L., Port E.R., et al. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer. Ann Surg Oncol 11 (2004) 535-541
25. Albo D., Ames F.C., Hunt K.K., Ross M.I., Singletary S.E., and Kuerer H.M. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat 77 (2003) 9-14
26. Blessing W.D., Stolier A.J., Teng S.C., Bolton J.S., and Fuhrman G.M. A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping. Am J Surg 184 (2002) 341-345
27. Raut C.P., Hunt K.K., Akins J.S., Daley M.D., Ross M.I., Singletary S.E., et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 104 (2005) 692-699
28. Hueter L., Schwarzkopf K., and Karzai W. Interference of patent blue V dye with pulse oximetry and co-oximetry. Eur J Anaesthesiol 22 (2005) 475-476
29. Pinero A., Illana J., Garcia-Palenciano C., Canizarese F., Canteras M., Caandillas V., et al. Effect on oximetry of dyes used for sentinel lymph node biopsy. Arch Surg 139 (2004) 1204-1207
30. El-Tamer M., Komenaka I.K., Curry S., Troxel A.B., Ditkoff B.A., and Schnabel F.R. Pulse oximeter changes with sentinel lymph node biopsy in breast cancer. Arch Surg 138 (2003) 1257-1260
31. Hoskin R.W., and Granger R. Intraoperative decrease in pulse oximeter readings following injection of isosulfan blue. Can J Anaesth 48 (2001) 38-40
32. Quiliquini A., Hogendijk S., and Hauser C. Anaphylaxis to patent blue. Dermatology 197 (1998) 400
33. Albo D., Wayne J.D., Hunt K.K., Rahlfs T.F., Singletary S.E., Ames F.C., et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 182 (2001) 393-398
34. Mertes P.M., and Laxenaire M.C. Allergy and anaphylaxis in anaesthesia. Minerva Anestesiol 70 (2004) 285-291
35. Fisher M.M., and Baldo B.A. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 80 (1998) 26-29
36. Raut C.P., Daley M.D., Hunt K.K., Akins J., Ross M.I., Singletary S.E., et al. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol 22 (2004) 567-568
37. Mertes P.M., Moneret-Vautrin D.A., Leynadier F., and Laxenaire M.C. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers. Anesthesiology 107 (2007) 245-252
38. Kalimo K., and Saarni H. Immediate reactions to patent blue dye. Contact Dermatitis 7 (1981) 171-172
39. Varghese P., Mostafa A., Abdel-Rahman A.T., Akberali S., Gattuso J., Canizales A., et al. Methylene blue dye versus combined dye-radioactive tracer technique for sentinel lymph node localisation in early breast cancer. Eur J Surg Oncol 33 (2007) 147-152
40. Golshan M., and Nakhlis F. Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?. Breast J 12 (2006) 428-430
41. Simmons R.M., Smith S.M., and Osborne M.P. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Breast J 7 (2001) 181-183
42. Stradling B., Aranha G., and Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am J Surg 184 (2002) 350-352
43. Salhab M., Al Sarakbi W., and Mokbel K. Skin and fat necrosis of the breast following methylene blue dye injection for sentinel node biopsy in a patient with breast cancer. Int Semin Surg Oncol 2 (2005) 26
44. Singh-Ranger G., and Mokbel K. Capsular contraction following immediate reconstructive surgery for breast cancer-an association with methylene blue dye. Int Semin Surg Oncol 1 (2004) 3
45. Dewachter P., Mouton-Faivre C., Trechot P., Lleu J.C., and Mertes P.M. Severe anaphylactic shock with methylene blue instillation. Anesth Analg 101 (2005) 149-150
46. Tsopelas C., and Sutton R. Why certain dyes are useful for localizing the sentinel lymph node. J Nucl Med 43 (2002) 1377-1382